SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc’s focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer’s disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of ASD and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seeds oil-based products on Amazon Marketplace.
Company profile
Ticker
SPRC
Exchange
Website
CEO
Gilad Bar-Lev
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
SciSparc Ltd./ADR, Therapix Biosciences Ltd.
SEC CIK
SPRC stock data
Latest filings (excl ownership)
425
Business combination disclosure
12 Apr 24
6-K
Agreement and Plan of Merger
11 Apr 24
S-8
Registration of securities for employees
1 Apr 24
20-F
2023 FY
Annual report (foreign)
1 Apr 24
6-K
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
27 Mar 24
6-K
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
15 Mar 24
6-K
Report of Foreign Private Issuer
13 Mar 24
6-K
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
8 Mar 24
EFFECT
Notice of effectiveness
7 Mar 24
6-K
Report of Foreign Private Issuer
29 Feb 24
Latest ownership filings
SC 13G
YA II PN, Ltd.
6 Mar 24
144
Notice of proposed sale of securities
21 Aug 23
SC 13G
Clearmind Medicine Inc.
13 Dec 22
SC 13G/A
EIDE ROBERT J
9 May 22
SC 13G/A
BIGGER CAPITAL FUND L P
11 Feb 22
SC 13G/A
BIGGER CAPITAL FUND L P
1 Feb 21
SC 13G
EIDE ROBERT J
9 Dec 20
SC 13D/A
L.I.A. Pure Capital Ltd
3 Dec 20
SC 13G
BIGGER CAPITAL FUND L P
30 Nov 20
SC 13G/A
MORGAN STANLEY
10 Aug 20
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2021
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 125.00 k |
Total shares | 11.22 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Eide Robert J | 11.20 mm | $0.00 |
Bigger Capital Fund L P | 20.04 k | $125.00 k |
News
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
16 Apr 24
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
16 Apr 24
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
11 Apr 24
SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
11 Apr 24
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
11 Apr 24
Press releases
SciSparc to Acquire AutoMax
11 Apr 24
Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
27 Mar 24
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
27 Mar 24
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
21 Mar 24
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
18 Mar 24